DZ3298A1 - Methode de maintien ou d'amelioration de la synthese de mucines - Google Patents

Methode de maintien ou d'amelioration de la synthese de mucines

Info

Publication number
DZ3298A1
DZ3298A1 DZ013298A DZ013298A DZ3298A1 DZ 3298 A1 DZ3298 A1 DZ 3298A1 DZ 013298 A DZ013298 A DZ 013298A DZ 013298 A DZ013298 A DZ 013298A DZ 3298 A1 DZ3298 A1 DZ 3298A1
Authority
DZ
Algeria
Prior art keywords
mucins
synthesis
maintaining
improving
disease states
Prior art date
Application number
DZ013298A
Other languages
English (en)
Inventor
Olivier Ballevre
Paul-Andre Finot
Denis Breuille
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27052980&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ3298(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/774,814 external-priority patent/US6833350B2/en
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of DZ3298A1 publication Critical patent/DZ3298A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DZ013298A 2000-02-04 2001-01-31 Methode de maintien ou d'amelioration de la synthese de mucines DZ3298A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49890500A 2000-02-04 2000-02-04
US09/774,814 US6833350B2 (en) 2000-02-04 2001-01-30 Method for maintaining or improving the synthesis of mucins
PCT/EP2001/001013 WO2001056405A2 (fr) 2000-02-04 2001-01-31 Methode de maintien ou d'amelioration de la synthese de mucines

Publications (1)

Publication Number Publication Date
DZ3298A1 true DZ3298A1 (fr) 2001-08-09

Family

ID=27052980

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ013298A DZ3298A1 (fr) 2000-02-04 2001-01-31 Methode de maintien ou d'amelioration de la synthese de mucines

Country Status (22)

Country Link
EP (1) EP1255452B2 (fr)
JP (1) JP2003533436A (fr)
CN (1) CN1434681B (fr)
AT (1) ATE323422T1 (fr)
AU (1) AU784137B2 (fr)
BG (1) BG106967A (fr)
BR (1) BRPI0108096B1 (fr)
CA (1) CA2399063C (fr)
CZ (1) CZ20022978A3 (fr)
DE (1) DE60118888T3 (fr)
DZ (1) DZ3298A1 (fr)
ES (1) ES2261383T5 (fr)
HR (1) HRP20020647A2 (fr)
HU (1) HUP0204439A3 (fr)
IL (1) IL150977A (fr)
MA (1) MA25656A1 (fr)
MX (1) MXPA02007491A (fr)
NO (1) NO20023640L (fr)
NZ (1) NZ520605A (fr)
PL (1) PL357078A1 (fr)
SK (1) SK11212002A3 (fr)
WO (1) WO2001056405A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2382874A1 (fr) 2003-06-23 2011-11-02 Nestec S.A. Supplémentation d'acides aminés pour un écosystème microbiotique sain
WO2007004613A1 (fr) 2005-07-01 2007-01-11 Ajinomoto Co., Inc. Agent thérapeutique contre l'affection abdominale inflammatoire et inhibiteur de la production de tnf-α
CA2631220A1 (fr) * 2006-01-09 2007-07-19 Nestec S.A. Traitement de patients stresses
WO2012133198A1 (fr) * 2011-03-25 2012-10-04 イーエヌ大塚製薬株式会社 Composition nutritionnelle pour maladies inflammatoires
CN103813796A (zh) 2011-07-22 2014-05-21 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道修复的低聚半乳糖
EP3167895A1 (fr) * 2015-11-10 2017-05-17 University College Dublin Complément alimentaire contenant du bêta-glucane et d'hydrolysat de caséine pour améliorer la santé et la performance de croissance chez un mammifère

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (fr) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
CA1338682C (fr) * 1988-12-23 1996-10-29 Gustavo Bounous Concentre de proteine non caseique, biologiquement actif, utile comme supplement alimentaire
JP2805490B2 (ja) * 1989-02-07 1998-09-30 雪印乳業株式会社 細菌毒素中和剤
JP3007694B2 (ja) * 1990-12-14 2000-02-07 雪印乳業株式会社 胃潰瘍予防または治療のための医薬及び飲食品
DE69331528T2 (de) * 1992-12-23 2002-10-31 Abbott Laboratories, Abbott Park Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
FR2711529B1 (fr) * 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
JPH07267855A (ja) * 1994-03-30 1995-10-17 Taiho Yakuhin Kogyo Kk グルタミン産生剤
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
US5670157A (en) * 1995-12-11 1997-09-23 Nestec Ltd. Method for reducing and controlling immunoglobulin concentrations
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
AU9625498A (en) * 1997-09-16 1999-04-05 Societe Des Produits Nestle S.A. Organ specific nutrition
CA2331921A1 (fr) * 1998-06-24 1999-12-29 Boyce Thompson Institute For Plant Research, Inc. Nouvel adnc mucin intestinal des invertebres et produits et procedes correspondants
EP1034704A1 (fr) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Composition nutritionnelle notamment pour la maturation gastro-intestinale spécifique dans des mammifères prématurés
EP1222275A2 (fr) * 1999-10-22 2002-07-17 The Board of Regents of the University of Nebraska Isoforme de serum amyloide a decouverte dans le colostrum

Also Published As

Publication number Publication date
DE60118888T3 (de) 2010-09-23
HUP0204439A2 (hu) 2003-04-28
NO20023640D0 (no) 2002-07-31
JP2003533436A (ja) 2003-11-11
AU4056401A (en) 2001-08-14
HRP20020647A2 (en) 2004-12-31
HUP0204439A3 (en) 2004-12-28
MXPA02007491A (es) 2002-12-13
DE60118888T2 (de) 2007-01-18
WO2001056405A3 (fr) 2002-01-24
EP1255452B2 (fr) 2010-03-03
PL357078A1 (en) 2004-07-12
CZ20022978A3 (cs) 2003-02-12
ES2261383T5 (es) 2010-06-18
ATE323422T1 (de) 2006-05-15
CN1434681A (zh) 2003-08-06
IL150977A0 (en) 2003-02-12
CN1434681B (zh) 2010-12-08
WO2001056405A2 (fr) 2001-08-09
BG106967A (bg) 2003-04-30
BRPI0108096B1 (pt) 2017-05-09
NZ520605A (en) 2004-06-25
NO20023640L (no) 2002-09-19
EP1255452A2 (fr) 2002-11-13
MA25656A1 (fr) 2002-12-31
CA2399063A1 (fr) 2001-08-09
BR0108096A (pt) 2002-10-29
IL150977A (en) 2005-09-25
SK11212002A3 (sk) 2003-01-09
DE60118888D1 (de) 2006-05-24
AU784137B2 (en) 2006-02-09
EP1255452B1 (fr) 2006-04-19
ES2261383T3 (es) 2010-06-14
CA2399063C (fr) 2014-01-28

Similar Documents

Publication Publication Date Title
TW200503708A (en) Gyrase inhibitors and uses thereof
ZA200701629B (en) Gyrase inhibitors and uses thereof
PL374191A1 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
WO2003077828A3 (fr) Antibiotiques de type florfenicol
TW200734344A (en) Antibacterial agents
EP1594444A4 (fr) Methodes et compositions destinees au traitement et a la prevention d'infections a staphylocoque ou autres infections bacteriennes
MY138708A (en) Biaryloxymethylarenecarboxylic acids
MXPA03011546A (es) Formulacion farmaceutica.
HUP0301819A2 (hu) Illóolajok alkalmazása Helicobacter-szerű organizmusok által előidézett gyomor- és bélrendszeri fertőzések leküzdésére
WO2003099217A3 (fr) Methodes de traitement d'infections bacteriennes et de maladies associees
WO2004011477A3 (fr) Ketolides pontes aux carbones 6,11-4
WO2005037839A8 (fr) Composes derives de norcantharidine, leurs procedes de preparation, les compositions les contenant et leurs utilisations.
MXPA04006266A (es) Pirimidotriazinas como inhibidores de fosfatasa.
SG48816A1 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
DZ3298A1 (fr) Methode de maintien ou d'amelioration de la synthese de mucines
DE60128112D1 (de) Aminoalkoxybenzoyl-benzofurane oder benzothiophene, verfahren zu ihrer herstellung und die enthaltenden zusammensetzungen
YU58102A (sh) Postupak za održavanje ili poboljšanje sinteze mucina
EP1594509A4 (fr) Compositions et methodes de traitement du syndrome du colon irritable et de la dyspepsie non ulcereuse
BRPI0409609A (pt) mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
WO2009089147A3 (fr) Procédés et compositions pour le traitement de cancers et d'infections pathogènes
WO2004071324A3 (fr) Procede permettant de reduire, eliminer ou prevenir la colonisation des oeufs et/ou de la volaille par des pathogenes bacteriens a l'aide de bacteriophages
CA2534483A1 (fr) Composition et methode de traitement du bezoard et du trichobezoard
BG107553A (en) Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same
WO2005121160A3 (fr) Agents antibacteriens macrolides de thiocarbamate cyclique 11,12
MXPA05006296A (es) Uso de tiazolobenzoheterociclos para el tratamiento de la esclerosis multiple.